Skip to main content

RBC Capital Keeps Their Buy Rating on Surgery Partners (SGRY)

Tipranks - Tipranks - Sat Dec 20, 2025

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Surgery Partners, with a price target of $31.00.

Claim 50% Off TipRanks Premium and Invest with Confidence

According to TipRanks, Hendrix is a 4-star analyst with an average return of 4.6% and a 51.76% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical.

In addition to RBC Capital, Surgery Partners also received a Buy from Mizuho Securities’s Ann Hynes in a report issued on December 18. However, yesterday, TR | OpenAI – 4o reiterated a Hold rating on Surgery Partners (NASDAQ: SGRY).

See Insiders’ Hot Stocks on TipRanks >>

Based on Surgery Partners’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $821.5 million and a GAAP net loss of $22.7 million. In comparison, last year the company earned a revenue of $770.4 million and had a GAAP net loss of $31.7 million

Read More on SGRY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).